Jaitip Tipanee
Overview
Explore the profile of Jaitip Tipanee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tipanee J, Samara-Kuko E, Gevaert T, Chuah M, VandenDriessche T
Mol Ther
. 2022 Jun;
30(10):3155-3175.
PMID: 35711141
Allogeneic CD19-specific chimeric antigen receptor (CAR) T cells with inactivated donor T cell receptor (TCR) expression can be used as an "off-the-shelf" therapeutic modality for lymphoid malignancies, thus offering an...
2.
Dastidar S, Majumdar D, Tipanee J, Singh K, Klein A, Furling D, et al.
Mol Ther
. 2021 Aug;
30(1):75-91.
PMID: 34371182
CTG repeat expansion (CTG) is associated with aberrant alternate splicing that contributes to cardiac dysfunction in myotonic dystrophy type 1 (DM1). Excision of this CTG repeat using CRISPR-Cas resulted in...
3.
Tipanee J, Di Matteo M, Tulalamba W, Samara-Kuko E, Keirsse J, Van Ginderachter J, et al.
Mol Ther Nucleic Acids
. 2020 Mar;
19:1309-1329.
PMID: 32160703
We established a semi-high-throughput in vivo screening platform using hyperactive piggyBac (hyPB) transposons (designated as PB-miR) to identify microRNAs (miRs) that inhibit hepatocellular carcinoma (HCC) development in vivo, following miR...
4.
Dastidar S, Ardui S, Singh K, Majumdar D, Nair N, Fu Y, et al.
Nucleic Acids Res
. 2018 Jun;
46(16):8275-8298.
PMID: 29947794
CRISPR/Cas9 is an attractive platform to potentially correct dominant genetic diseases by gene editing with unprecedented precision. In the current proof-of-principle study, we explored the use of CRISPR/Cas9 for gene-editing...
5.
Tipanee J, Chai Y, VandenDriessche T, Chuah M
Biosci Rep
. 2017 Nov;
37(6).
PMID: 29089466
Transposons derived from (SB), (PB), or typically require cotransfection of transposon DNA with a transposase either as an expression plasmid or mRNA. Consequently, this results in genomic integration of the...
6.
Tipanee J, VandenDriessche T, Chuah M
Hum Gene Ther
. 2017 Sep;
28(11):1087-1104.
PMID: 28920716
Transposons have emerged as promising vectors for gene therapy that can potentially overcome some of the limitations of commonly used viral vectors. Transposons stably integrate into the target cell genome,...
7.
Likhitrattanapisal S, Tipanee J, Janvilisri T
Tumour Biol
. 2016 Jul;
37(9):12755-12766.
PMID: 27448818
Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the members of hepatobiliary diseases. Both types of cancer often exert high levels of similarity in terms of phenotypic characteristics, thus leading to...